Company / Interest Expense
DaVita Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$539.9M
FY2025
5-year range
$267.0M / $539.9M
FY2021-FY2025
Trend
+24.1%
vs FY2024
Sector context
#8 of 44
Health Care
What the data says
DaVita's interest expense of $540M is higher than 82% of companies in the Health Care sector (FY2025). Interest Expense has fluctuated over the past 10 years, ranging from $267M in FY2023 to $540M in FY2025.
Based on SEC 10-K filings.
$540M in FY2025 with a 5-year CAGR of +3.2%. Top quartile in the Health Care sector.
Increased from $267M to $540M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +24.0%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 44This company $539.9M Sector average $316.9M
▼
+70.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.2%, indicating consistent growth.
- In FY2025, interest expense increased 24.1% year-over-year.
- Ranks #8 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $539.9M | +24.1% |
| FY2024 | $435.2M | +63.0% |
| FY2023 | $267.0M | -5.6% |
| FY2022 | $282.9M | -32.6% |
| FY2021 | $419.6M | -9.1% |
| FY2020 | $461.9M | +13.7% |
| FY2019 | $406.3M | +3.1% |
| FY2018 | $394.0M | -3.0% |
| FY2017 | $406.3M | +3.1% |
| FY2016 | $394.0M | +1.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026